The therapeutic value of poly(ethylene glycol)-modified proteins
- 30 April 1991
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 6 (2), 133-151
- https://doi.org/10.1016/0169-409x(91)90037-d
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Effects of Coupling Chemistry on the Activity of Poly(ethylene glycol)-Modified Alkaline PhosphataseJournal of Bioactive and Compatible Polymers, 1989
- Adenosine deaminase deficiency with late onset of recurrent infections: Response to treatment with polyethylene glycol-modified adenosine deaminaseThe Journal of Pediatrics, 1988
- Treatment of Adenosine Deaminase Deficiency with Polyethylene Glycol–Modified Adenosine DeaminaseNew England Journal of Medicine, 1987
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985
- Acylation of human hemoglobin with polyoxyethylene derivativesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1984
- Modification of batroxobin with activated polyethylene glycol: Reduction of binding ability towards anti-batroxobin antibody and retention of defibrinogenation activity in circulation of preimmunized dogsLife Sciences, 1983
- Hemoglobin-inulin conjugate as an oxygen carrying blood substituteBiochemical and Biophysical Research Communications, 1983
- Modification of human hemoglobin with polyethylene glycol: A new candidate for blood substituteBiochemical and Biophysical Research Communications, 1980
- Modification of E. coli L-asparaginase with polyethylene glycol: Disappearance of binding ability to anti-asparaginase serumBiochemical and Biophysical Research Communications, 1978
- Effects of superoxide radicals on myoblast growth and differentiationBiochemical and Biophysical Research Communications, 1974